Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7410
-0.0484 (-6.13%)
At close: Jun 27, 2025, 4:00 PM
0.7665
+0.0255 (3.44%)
After-hours: Jun 27, 2025, 5:36 PM EDT
Cue Biopharma Employees
Cue Biopharma had 41 employees as of December 31, 2024. The number of employees decreased by 12 or -22.64% compared to the previous year.
Employees
41
Change (1Y)
-12
Growth (1Y)
-22.64%
Revenue / Employee
$194,902
Profits / Employee
-$989,854
Market Cap
55.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CUE News
- 3 days ago - Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company's Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease - GlobeNewsWire
- 6 weeks ago - Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Cue Biopharma to Host Virtual Investor Event on May 15, 2025 - GlobeNewsWire
- 7 weeks ago - Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference - GlobeNewsWire
- 2 months ago - Cue Biopharma, Inc. (CUE) Business Update Call (Transcript) - Seeking Alpha
- 2 months ago - Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases - GlobeNewsWire
- 2 months ago - Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering - GlobeNewsWire
- 2 months ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire